Gabriela M Webb, Kristin A Sauter, Diana Takahashi, Melissa Kirigiti, Lindsay Bader, Sarah R Lindsley, Hannah M Blomenkamp, Cicely Zaro, Molly Shallman, Casey M McGuire, Heather Hofmeister, Uriel Avila, Cleiton Pessoa, Joseph M Hwang, Allyson J McCullen, Matthew Humkey, Jason Reed, Lina Gao, Lee Winchester, Courtney V Fletcher, Oleg Varlamov, Todd T Brown, Jonah B Sacha, Paul Kievit, Charles T Roberts
Current antiretroviral therapy (ART) regimens efficiently limit HIV replication, thereby improving life expectancy of people living with HIV, but also cause metabolic side effects. The ongoing obesity epidemic has resulted in more people with metabolic comorbidities at the time of HIV infection, yet the impact of pre-existing metabolic dysregulation on infection sequelae and response to ART is unclear. Here, to investigate the impact of preexisting obesity and insulin resistance on acute infection and subsequent long-term ART, we infected a cohort of lean and obese adult male macaques with SIV and administered ART...
August 8, 2024: JCI Insight